- Report
- October 2024
- 180 Pages
Global
From €3386EUR$3,545USD£2,831GBP
€3762EUR$3,939USD£3,146GBP
- Report
- June 2024
- 200 Pages
Global
From €7593EUR$7,950USD£6,349GBP
- Report
- July 2024
- 138 Pages
Global
From €2388EUR$2,500USD£1,997GBP
- Report
- August 2024
- 81 Pages
Global
From €3500EUR$3,926USD£3,029GBP
Malabsorption Syndrome Drugs are a type of Gastrointestinal Drugs used to treat malabsorption syndrome, a condition in which the body is unable to absorb nutrients from food. These drugs are used to replace the missing nutrients and help the body absorb them. Commonly used drugs include pancreatic enzymes, bile acid sequestrants, and probiotics. Pancreatic enzymes are used to replace the enzymes that the pancreas is unable to produce, while bile acid sequestrants are used to bind bile acids and prevent them from being reabsorbed. Probiotics are used to restore the balance of beneficial bacteria in the gut.
Some companies in the Malabsorption Syndrome Drug market include AbbVie, Allergan, AstraZeneca, Bayer, GlaxoSmithKline, Merck, Novartis, Pfizer, and Takeda. Show Less Read more